Top Story

First-line fulvestrant extended OS in advanced, ER-positive breast cancer

December 22, 2014

SAN ANTONIO — First-line fulvestrant significantly extended OS compared with anastrozole in women with advanced, ER-positive breast cancer, according to results of the phase 2 FIRST study presented at the San Antonio Breast Cancer Symposium.

Prior research demonstrated fulvestrant (Faslodex, AstraZeneca) was associated with prolonged disease control compared with anastrozole (Arimidex, AstraZeneca) in the second-line setting.

Neurocrine Biosciences launches trial for congenital adrenal hyperplasia therapy

December 21, 2014
After completing a pilot clinical trial in adults with classic congenital adrenal hyperplasia, Neurocrine Biosciences, Inc. announced a trial for its…
Ixazomib may provide more convenient, effective treatment for multiple myeloma Meeting News CoverageVideo

Ixazomib may provide more convenient, effective treatment for multiple myeloma

December 21, 2014
SAN FRANCISCO — Shaji K. Kumar, MD, professor of medicine at the Mayo Clinic in Rochester, Minn., discusses the experimental agent, ixazomib, which may…

Top five ophthalmology news stories this week

December 21, 2014
This week, the most frequently viewed ophthalmology articles on Healio.com ranged from topics such as the OSN New York meeting to Genentech’s receipt of the U.S. Food…
More News Headlines »
In the Journals

Novel, cheap DNA sequencer identified S. typhi resistance

December 21, 2014
A novel nanopore DNA sequencer could rapidly diagnose infection at a greatly reduced price, according to recent…
More »
Blog

Introducing Angela Bedell, OWL’s new executive director

December 15, 2014
On behalf of Ophthalmic Women Leaders, I am pleased to introduce to the ophthalmic community our new executive…
More »
Meeting News Coverage Video
Vosaroxin combination demonstrated improved survival in AML

Vosaroxin combination demonstrated improved survival in AML

December 20, 2014
SAN FRANCISCO — Farhad Ravandi, MD, professor of medicine in the department of leukemia at The University of…
More »
morganatic-roan